Header

Pelubi Tab, Pelubi CR Tab(Pd No. : 3076278)

(Updated : Dec/26/2016)
product information
Model Nm Pelubiprofen 30mg / 45mg
HS CODE 300490
M.O.Q 680,000 Tab
Ceritification
Keywords NSAIDs, Analgesic, Antipyretics, ETC, Pharmaceutical product
Seller ID dwpharm
  • SHARE

[Company Introduction]


In 1958, Daewon Pharm was established on the basis of founding idea: “the realization of human health.” Although we went through chronological changes, it has been our unchanging role and mission to protect the public health as a company specialized in therapeutic agents.


Daewon Pharm is a capable company that has developed new drugs using excellent technological basis and manufacturing facility. We are devoting ourselves to develop numerous new products to improve the quality of life, and trying our best to become the representative pharmaceutical company of the Republic of Korea.


With the mission statement, “Based on our customer’s belief and trust, be a companion that protects the healthy human life,” Daewon Pharm is ready to make new history in the next 100 years to go beyond a-half-century long reputation of being a therapeutic agent specialist.


Please keep us in your sight as we are trying to put our best efforts on social responsibilities, and developing good products to protect the health and happiness. 


In return for your constant support, we all executives and the staffs at Daewon Pharm will always strive to prepare for the future.


Thank you.



[Product Description]


The Pelubi / Pelubi CR tablet, a series of NSAIDs developed from raw materials to finished product by Daewon Pharm.Co.Ltd., was certificated as the 12th new medicine by The Korean Food and Drug Administration. It is NSAIDs that is highly effective for pain relief and has less side effects in comparison with existing NSAIDs products.



[Product Features]


Brand name: Pelubi Tab. / Pelubi CR Tab.


Composition: Each tablet contains, Pelubiprofen 30mg / 45mg


Description: Lemon yellow circular tablet


Indication: Reduce symptoms of Osteoarthritis, Rheumatoid arthritis, Back pain, Fever


Dosage and Administration: 1 tab.(30mg), 3 times daily after a meal - Pelubi


                                                 1 tab.(45mg), twice daily – Pelubi CR


Storage: Light-resistant, well-closed container at room temperature


Package: Blister


Use term: 3 years


※ The packing unit of all products can be changed as required by order.


※ This drug is manufactured in accordance with KGMP as recommended by WHO.

Company Information

company information
Contact Person Lee, Eun-Hyong
Company Daewon Pharmaceutical Co., Ltd.
Address 467-24, Kungja-dong, Kwangjin-ku, Seoul, Korea
Homepage www.daewonpharm.com , http://seller.buykorea.org/daewon-pharmaceutical--1012562
Tel 0222047000 Fax 024999110
Biz. Type Est. Year
Employees Annual Export USD 0~1 mn
Related Business Event List
GBMP 2017 2017-03-16 ~ 2017-03-17
Global Bio Pharma Plaza(GBPP 2017) 2017-11-27 ~ 2017-11-28
Africa Health 2017(Johannesburg, South Africa) 2017-06-07 ~ 2017-06-09
2017 GBMP Public Procurement Plaza 2017-03-16 ~ 2017-03-17
GBMP 2017 [Hospital Projects] 2017-03-16 ~ 2017-03-17
KOREA CONSUMER GOODS SHOWCASE 2017 COEX D HALL 2017-06-15 ~ 2017-06-16
GBMP 2017 [Medical Devices] 2017-03-16 ~ 2017-03-17
Innovation & Technology Business Partnering 2017 COEX Intercontinental, Seoul, South Korea 2017-03-29 ~ 2017-03-30
Convention on Pharmaceutical Ingredients China 2017 2017-06-20 ~ 2017-06-22
InnoMedi 2017-03-29 ~ 2017-03-29
KOREA CONSUMER GOODS SHOWCASE 2017 COEX D HALL 2017-06-15 ~ 2017-06-16
Korea-Saudi joint committee Business meeting Lotte Hotel Jamsil 2017-10-26 ~ 2017-10-26
Global Medical Equipment Plaza 2018 2018-03-15 ~ 2018-03-15
Convention on Pharmaceutical Ingredients China 2018 2018-06-20 ~ 2018-06-22
Go to the top of the page
Loading...